Cargando…
A chemotherapy response classifier based on support vector machines for high-grade serous ovarian carcinoma
Long-term outcome of high-grade serous epithelial ovarian carcinoma (HGSOC) remains poor as a result of recurrence and the emergence of drug resistance. Almost all the patients were given the same platinum-based chemotherapy after debulking surgery even though some of them are naturally resistant to...
Autores principales: | Sun, Chao-Yang, Su, Tie-Fen, Li, Na, Zhou, Bo, Guo, En-Song, Yang, Zong-Yuan, Liao, Jing, Ding, Dong, Xu, Qin, Lu, Hao, Meng, Li, Wang, Shi-Xuan, Zhou, Jian-Feng, Xing, Hui, Weng, Dan-Hui, Ma, Ding, Chen, Gang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4823103/ https://www.ncbi.nlm.nih.gov/pubmed/26675546 http://dx.doi.org/10.18632/oncotarget.6569 |
Ejemplares similares
-
VISTA expression is associated with a favorable prognosis in patients with high-grade serous ovarian cancer
por: Zong, Liju, et al.
Publicado: (2019) -
Understanding the impact of chemotherapy on the immune landscape of high-grade serous ovarian cancer
por: Vanguri, Rami, et al.
Publicado: (2022) -
Identification of Prognosis Biomarkers for High-Grade Serous Ovarian Cancer Based on Stemness
por: Wang, Zhihang, et al.
Publicado: (2022) -
Low-grade Serous Ovarian Carcinoma
por: Ricciardi, Enzo, et al.
Publicado: (2018) -
Spatial heterogeneity of infiltrating T cells in high-grade serous ovarian cancer revealed by multi-omics analysis
por: Yang, Bin, et al.
Publicado: (2022)